InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
6
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Barry James Christopher, Chairman & CEO. Officer active across 2 companies, notably NUVASIVE INC. Aggregated, 14 reports have been logged. Breakdown: 0 buy · 6 sells. Total volume traded: €1.7m. Activity tracked since 21 June 2021. The latest transaction was disclosed on 15 December 2024 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations14 total
4,042 sharesOrdinary SharesSEC:0001639691-26-000073:0
486 sharesOrdinary SharesSEC:0001639691-26-000073:1
1,709 shares0Ordinary SharesSEC:0001639691-24-000149:0
72,997 sharesCommon Stock, par value $0.001 per shareSEC:0001209191-23-048164:0
34,284 shares0Common StockSEC:0001209191-23-015840:0
5,000 shares@ US$58.0015.9% of flowCommon StockSEC:0001209191-22-024530:0
5,000 shares@ US$55.0014.9% of flowCommon StockSEC:0001209191-22-021639:0
53,523 shares0Common StockSEC:0001209191-22-015756:0
29,904 shares0Common StockSEC:0001209191-21-063680:0
29,904 shares0Common StockSEC:0001209191-21-063680
5,000 shares@ US$70.0017.5% of flowCommon StockSEC:0001209191-21-043720
5,000 shares@ US$70.0017.5% of flowCommon StockSEC:0001209191-21-043720:0
5,000 shares@ US$68.0017.1% of flowCommon StockSEC:0001209191-21-042809
5,000 shares@ US$68.0017.1% of flowCommon StockSEC:0001209191-21-042809:0
14 of 14 declarations
About Barry James Christopher
James Christopher Barry is the President and CEO of NUVASIVE INC. As the leader of the company, he oversees strategic operations and ensures growth and innovation. NUVASIVE INC. specializes in medical devices. James plays a key role in developing the company's vision and objectives.
